Skip to main content
Clinical Trials/IRCT20120305009213N5
IRCT20120305009213N5
Completed
未知

The effect of peri-operative magnesium sulfate infusion on inflammatory factors in patients with lung cancer

Cancer institute0 sites44 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
Cancer institute
Enrollment
44
Status
Completed
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Cancer institute

Eligibility Criteria

Inclusion Criteria

  • Patients with stage I (cT1N0 and cT2N0\), stage II (cT1N1, cT2N1 and cT3N0\) lung cancer
  • Age 18 to 65 years old
  • Candidate for lobectomy or pneumoectomy surgery
  • Informed consent

Exclusion Criteria

  • History of severe heart disease, severe systemic and functional lung disease (asthma, COPD)
  • Electrolyte disturbance
  • BMI below 16
  • concurrent history of other cancers
  • Albumin level less than 5\.2
  • stage IIIA (cT3N1 and cT1–3N2\) lung cancer and above
  • Small cell carcinoma
  • HIV positive or any immunodeficiency
  • Patients undergoing clinical trial studies at the same time as this study
  • Dissatisfaction with participating in the study

Outcomes

Primary Outcomes

Not specified

Similar Trials